Harry Yoon in Rochester, Minnesota

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY, INTERNAL MEDICINE

Medical School: Yale University School Of Medicine
Graduation Year: 2001
The Primary Medical Specialty for Harry Yoon is listed as: Medical Oncology
Approximate Years of Experience: 23
PAC (PECOS ID)#: 9830264639
NPI #: 1255408258
NPI Created On: 11/29/2006
NPI Last Updated Listed as: 08/21/2020
Primary Taxonomy Code: 207RH0003X
License Number:
50742
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medica Health Plans of Wisconsin
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
2. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
4. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
5. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
6. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
7. Infusion of chemotherapy into a vein up to 1 hour
8. Infusion of chemotherapy into a vein
9. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
10. New patient office or other outpatient visit, typically 45 minutes
11. New patient office or other outpatient visit, typically 60 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
14. Injection, leucovorin calcium, per 50 mg
15. Injection, dexamethasone sodium phosphate, 1 mg
16. Injection, diphenhydramine hcl, up to 50 mg
17. Injection, fosaprepitant, 1 mg
18. Injection, ondansetron hydrochloride, per 1 mg
19. Injection, palonosetron hcl, 25 mcg
20. Unclassified drugs

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).